- Home
- LYFT vs CRL Comparison
LYFT vs CRL Comparison
Compare LYFT & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYFT | CRL |
|---|---|---|
| Founded | 2007 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.0B |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LYFT | CRL |
|---|---|---|
| Price | $19.17 | $194.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 32 | 15 |
| Target Price | $22.68 | ★ $190.15 |
| AVG Volume (30 Days) | ★ 13.5M | 884.6K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $6,273,827,000.00 | $4,023,704,000.00 |
| Revenue This Year | $14.36 | N/A |
| Revenue Next Year | $14.15 | $1.66 |
| P/E Ratio | $56.14 | ★ N/A |
| Revenue Growth | ★ 14.90 | N/A |
| 52 Week Low | $9.66 | $91.86 |
| 52 Week High | $25.54 | $199.66 |
Technical Indicators
Market Signals| Indicator | LYFT | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | 65.36 |
| Support Level | $18.61 | $192.09 |
| Resistance Level | $20.75 | $200.58 |
| Average True Range (ATR) | 0.96 | 4.98 |
| MACD | -0.32 | 1.83 |
| Stochastic Oscillator | 10.17 | 78.63 |
Price Performance
Historical ComparisonAbout LYFT Lyft Inc.
Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.